GlaxoSmithKline Consumer Healthcare [NYSE: GSK] announces that alliâ„¢, the only FDA-approved over-the-counter weight loss product will be on shelves of pharmacies, grocery stores and mass merchandisers nationwide later this week. alli is designed to be a partner for overweight adults willing to change how they eat and lose weight gradually. Adding alli to diet and exercise can help people lose 50 per cent more weight than with dieting alone.
Get the full story...
